120 related articles for article (PubMed ID: 15840604)
1. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
Della Rossa A; Tavoni A; Merlini G; Baldini C; Sebastiani M; Lombardi M; Neglia D; Bombardieri S
Rheumatology (Oxford); 2005 Aug; 44(8):1074-5. PubMed ID: 15840604
[No Abstract] [Full Text] [Related]
2. Refractory Takayasu arteritis successfully treated with infliximab.
Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
Filocamo G; Buoncompagni A; Viola S; Loy A; Malattia C; Ravelli A; Martini A
J Pediatr; 2008 Sep; 153(3):432-4. PubMed ID: 18718263
[TBL] [Abstract][Full Text] [Related]
4. Infliximab in Takayasu arteritis: a safe alternative?
Karageorgaki ZT; Mavragani CP; Papathanasiou MA; Skopouli FN
Clin Rheumatol; 2007 Jun; 26(6):984-7. PubMed ID: 16633710
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of infliximab for treating Takayasu arteritis.
Killinger Z; Cierny D; Jackuliak P; Zelinkova Z; Rovensky J; Payer J
Isr Med Assoc J; 2012 Dec; 14(12):771-3. PubMed ID: 23393718
[No Abstract] [Full Text] [Related]
6. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
8. Takayasu arteritis in children and adolescents.
Brunner J; Feldman BM; Tyrrell PN; Kuemmerle-Deschner JB; Zimmerhackl LB; Gassner I; Benseler SM
Rheumatology (Oxford); 2010 Oct; 49(10):1806-14. PubMed ID: 20562196
[TBL] [Abstract][Full Text] [Related]
9. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
10. Takayasu Arteritis: It Is Time to Work Together.
Beckman JA
Circulation; 2015 Nov; 132(18):1685-6. PubMed ID: 26354798
[No Abstract] [Full Text] [Related]
11. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab.
Tatò F; Rieger J; Hoffmann U
Int Angiol; 2005 Sep; 24(3):304-7. PubMed ID: 16158044
[TBL] [Abstract][Full Text] [Related]
12. Bacillus calmette-guérin vaccination in a patient treated with infliximab.
Toussirot E; Wendling D
J Rheumatol; 2005 Dec; 32(12):2500-1. PubMed ID: 16331800
[No Abstract] [Full Text] [Related]
13. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
Tse SM; Burgos-Vargas R; Laxer RM
Arthritis Rheum; 2005 Jul; 52(7):2103-8. PubMed ID: 15986366
[TBL] [Abstract][Full Text] [Related]
14. Takayasu arteritis: anti-TNF therapy in a Brazilian setting.
Nunes G; Neves FS; Melo FM; de Castro GR; Zimmermann AF; Pereira IA
Rev Bras Reumatol; 2010; 50(3):291-8. PubMed ID: 21125165
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of genital ulcers with infliximab in Behcet's disease.
Haugeberg G; Velken M; Johnsen V
Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
[No Abstract] [Full Text] [Related]
16. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
17. Takayasu's aortitis and infliximab.
El-Matary W; Persad R
J Pediatr; 2009 Jul; 155(1):151. PubMed ID: 19559311
[No Abstract] [Full Text] [Related]
18. Infliximab efficiency and failure.
Rozin AP
Ann Rheum Dis; 2004 Jun; 63(6):751-2; author reply 752. PubMed ID: 15140791
[No Abstract] [Full Text] [Related]
19. Infliximab infusions for persistent back pain in two patients with Schmorl's nodes.
Sakellariou GT; Chatzigiannis I; Tsitouridis I
Rheumatology (Oxford); 2005 Dec; 44(12):1588-90. PubMed ID: 16234274
[No Abstract] [Full Text] [Related]
20. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
